Generic Dabigatran for Cancer-Associated Venous Thromboembolism: Real-World Data
Author:
Publisher
Springer Science and Business Media LLC
Link
https://link.springer.com/content/pdf/10.1007/s12288-024-01745-7.pdf
Reference5 articles.
1. Khorana AA, Mackman N, Falanga A, Pabinger I, Noble S, Ageno W et al (2022) Cancer-associated venous thromboembolism. Nat Rev Dis Primer 8:1–18
2. Ganetsky M, Babu KM, Salhanick SD, Brown RS, Boyer EW (2011) Dabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant. J Med Toxicol 7:281–287
3. Desai R, Koipallil GK, Thomas N, Mhaskar R, Visweshwar N, Laber D et al (2020) Efficacy and safety of direct oral anticoagulants for secondary prevention of cancer associated thrombosis: a meta-analysis of randomized controlled trials. Sci Rep 10:18945
4. Lyman GH, Carrier M, Ay C, Di Nisio M, Hicks LK, Khorana AA et al (2021) American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv 5:927–974
5. Falanga A, Ay C, Nisio MD, Gerotziafas G, Jara-Palomares L, Langer F et al (2023) Venous thromboembolism in cancer patients: ESMO clinical practice guideline. Ann Oncol 34:452–467
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3